Elsevier

Cell Calcium

Volume 22, Issue 2, August 1997, Pages 75-82
Cell Calcium

Research
Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca2+-permeable channel

https://doi.org/10.1016/S0143-4160(97)90107-XGet rights and content

Abstract

In MCF-7 breast cancer cells, insulin-like growth factor-1 (IGF-1) increased the calcium-permeability of the cells by activating a voltage-independent calcium-permeable channel. IGF-1 also induced oscillatory elevation of cytoplasmic free calcium concentration in these cells. An anti-allergic compound, tranilast, reduced the calcium-permeability augmented by IGF-1 in a dose-dependent manner and blocked the oscillatory elevation of cytoplasmic free calcium concentration. Tranilast did not affect early intracellular signals activated by IGF-1, including receptor autophosphorylation, activations of Ras, mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Tranilast inhibited increases in [3H]-thymidine incorporation, DNA content and cell number induced by IGF-1. The ID50 for [3H]-thymidine incorporation and DNA content were about 10 μM. The inhibitory effect of tranilast was reversible, and cell viability was not affected. Treatment with tranilast increased the number of cells in the G1 phase suggesting that this compound induced G1 arrest. Tranilast also reduced the phosphorylation of the retinoblastoma protein. These results indicate that tranilast inhibits the IGF-1-induced cell growth in MCF-7 cells by blocking calcium entry.

References (32)

  • R.A. Weinberg

    The retinoblastoma protein and cell cycle control

    Cell

    (1995)
  • N. Takuwa et al.

    Ca2+-dependent stimulation of retinoblastoma gene product phosphorylation and p34cdc2 kinase activation in serum-stimulated human fibroblasts

    J Biol Chem

    (1993)
  • K. Polyak et al.

    Cloning of p27, a cyclin-dependent kinase inhibitor and a potent mediator of extracellular antimitogenic signals

    Cell

    (1994)
  • H. Rasmussen

    Calcium and cAMP as Synarchic Messengers

    (1981)
  • K.P. Lu et al.

    Regulation of the cell cycle by calcium and calmodulin

    Endocr Rev

    (1993)
  • C.D. Rasmussen et al.

    Calmodulin is required for cell-cycle progression during G1 and mitosis

    EMBO J

    (1989)
  • Cited by (66)

    • Valdecoxib blocks rat TRPV2 channels

      2022, European Journal of Pharmacology
    • Role of transient receptor potential vanilloid subtype 2 in lower oesophageal sphincter in rat acid reflux oesophagitis

      2021, Journal of Pharmacological Sciences
      Citation Excerpt :

      There are several compounds targeting TRPV2 inhibition for therapy, such as lumin, probenecid, cannabidiol, and tranilast.36 Tranilast has been reported to be a blocker of TRPV2 Ca2+-activity37–39 and pharmacological evidence suggests that it is a TRPV2 antagonist in various disease models.36,37,40 In this study, body weight loss, and increase of erosive lesions and epithelial thickness in mucosa were attenuated by treatment with tranilast.

    • Transient receptor potential channel regulation by growth factors

      2021, Biochimica et Biophysica Acta - Molecular Cell Research
      Citation Excerpt :

      In this study, it was shown that IGF-1 stimulation induced Ca2+ influx and membrane currents in CHO cells overexpressing TRPV2. An earlier study by the same group already identified that in MCF-7 breast cancer cells, IGF-1 dependent Ca2+ influx and proliferation could be diminished by tranilast, a TRPV2 inhibitor [50]. These findings were confirmed in a more recent study, in which it was demonstrated that in retinal pigment epithelial cells, incubation with IGF-1 increased current density of TRPV2 [51].

    • TRPV2 channel inhibitors attenuate fibroblast differentiation and contraction mediated by keratinocyte-derived TGF-β1 in an in vitro wound healing model of rats

      2018, Journal of Dermatological Science
      Citation Excerpt :

      Stretch-triggered cation channels were shown to be blocked by the TRPV2 inhibitor tranilast in retinal arterioles [39]. Furthermore, several growth factors (insulin and insulin-like growth factor-1) and serum induced the translocation of TRPV2 from an intracellular compartment to the plasma membrane, which was inhibited by tranilast [23,24]. Therefore, it is possible that the initial gel contraction and growth factors could be triggers to activate TRPV2 channels expressed on fibroblasts and keratinocytes.

    View all citing articles on Scopus
    View full text